Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma

Completed · Phase 1

Conditions studied: Multiple Myeloma

In brief

The purpose of the study is to assess the safety, tolerability and activity of a once-weekly regimen of carfilzomib in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma.

Key facts

Study ID

NCT02335983

Run by

Amgen

People needed

107

Starts

2015-04-30

Expected to finish

2019-10-28

Last updated by the study team

2020-11-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center — Bakersfield, California, United States
• Research Site — Burbank, California, United States
• Providence Saint Joseph Medical Center — Burbank, California, United States
• Research Site — Fountain Valley, California, United States
• Compassionate Care Research Group, Inc. — Fountain Valley, California, United States
• Research Site — Los Angeles, California, United States
• Research Site — Los Angeles, California, United States
• Los Angeles Hematology / Oncology Medical Group — Los Angeles, California, United States
• Research Site — Whittier, California, United States
• Research Site — Aurora, Colorado, United States
• University of Colorado — Aurora, Colorado, United States
• Research Site — Washington D.C., District of Columbia, United States
• Lombardi Cancer Center, Pediatric Hematology Oncology — Washington D.C., District of Columbia, United States
• Research Site — Fort Myers, Florida, United States
• Florida Cancer Specialists — Fort Myers, Florida, United States
• Research Site — Tampa, Florida, United States
• H. Lee Moffitt Cancer Center & Research Institute — Tampa, Florida, United States
• Research Site — West Palm Beach, Florida, United States
• Florida Cancer Specialists — West Palm Beach, Florida, United States
• University of Chicago Medical Center — Chicago, Illinois, United States
• Research Site — Boston, Massachusetts, United States
• Dana Farber Partners Cancer Care — Boston, Massachusetts, United States
• Research Site — Ann Arbor, Michigan, United States
• Research Site — Hackensack, New Jersey, United States
• Research Site — Bakersfield, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.